NeuroSense Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRSN and other ETFs, options, and stocks.

About NRSN

Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS). 

CEO
Alon Ben-Noon
CEOAlon Ben-Noon
Employees
15
Employees15
Headquarters
Herzliya, Tel Aviv
HeadquartersHerzliya, Tel Aviv
Founded
2017
Founded2017
Employees
15
Employees15

NRSN Key Statistics

Market cap
23.25M
Market cap23.25M
Price-Earnings ratio
-1.32
Price-Earnings ratio-1.32
Dividend yield
Dividend yield
Average volume
275.97K
Average volume275.97K
High today
$0.79
High today$0.79
Low today
$0.71
Low today$0.71
Open price
$0.71
Open price$0.71
Volume
144.22K
Volume144.22K
52 Week high
$2.60
52 Week high$2.60
52 Week low
$0.63
52 Week low$0.63

Stock Snapshot

The current NeuroSense Therapeutics(NRSN) stock price is $0.79, with a market capitalization of 23.25M. The stock trades at a price-to-earnings (P/E) ratio of -1.32.

On 2026-03-25, NeuroSense Therapeutics(NRSN) stock traded between a low of $0.71 and a high of $0.79. Shares are currently priced at $0.79, which is +11.3% above the low and 0.0% below the high.

The NeuroSense Therapeutics(NRSN)'s current trading volume is 144.22K, compared to an average daily volume of 275.97K.

During the past year, NeuroSense Therapeutics(NRSN) stock moved between $0.63 at its lowest and $2.60 at its peak.

During the past year, NeuroSense Therapeutics(NRSN) stock moved between $0.63 at its lowest and $2.60 at its peak.

People also own

Based on the portfolios of people who own NRSN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.